Ritholtz Wealth Management bought a new position in shares of Maximus, Inc. (NYSE:MMS – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 9,508 shares of the health services provider’s stock, valued at approximately $609,000.
Other hedge funds have also modified their holdings of the company. Dimensional Fund Advisors LP raised its stake in Maximus by 2.0% during the third quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock worth $170,812,000 after purchasing an additional 36,989 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Maximus by 19.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider’s stock valued at $18,304,000 after buying an additional 33,136 shares during the period. Divisadero Street Capital Management LP grew its stake in shares of Maximus by 93.5% in the 3rd quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider’s stock valued at $16,800,000 after buying an additional 88,872 shares during the period. WINTON GROUP Ltd acquired a new stake in shares of Maximus during the 3rd quarter worth approximately $6,208,000. Finally, Assenagon Asset Management S.A. acquired a new stake in shares of Maximus during the 4th quarter worth approximately $15,673,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Maximus Stock Down 1.3%
NYSE:MMS opened at $53.73 on Wednesday. Maximus, Inc. has a 52 week low of $52.73 and a 52 week high of $100.00. The stock’s fifty day moving average is $61.15 and its two-hundred day moving average is $73.44. The stock has a market capitalization of $2.82 billion, a price-to-earnings ratio of 8.04 and a beta of 0.58. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87.
Maximus Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Friday, May 15th. Maximus’s dividend payout ratio is currently 19.76%.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on MMS shares. Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Two analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.
Get Our Latest Analysis on Maximus
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
See Also
- Five stocks we like better than Maximus
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
